Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib-A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata. [PDF]
Dermatol Ther (Heidelb), 2023 Alopecia areata (AA) is a cell-mediated autoimmune disease in which a cytotoxic T-cell response against hair follicles occurs. AA has been demonstrated to frequently co-exist with atopic dermatitis (AD), and the coincidence of atopy predisposes to a more
Kołcz K +3 more
europepmc +2 more sources
JAMA Dermatol, 2023 Importance Prevalences of alopecia areata (AA), alopecia totalis (AT), and alopecia universalis (AU) are poorly established. Objective To estimate overall and subgroup prevalences of AA and its subtypes.
Sy N, Mastacouris N, Strunk A, Garg A.
europepmc +2 more sources
A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme. [PDF]
Vaccines (Basel), 2023 COVID-19 vaccines have positively changed the course of the pandemic. They entered the market after only one year of the initial trials, which that yielded positive results in terms of safety and efficacy. However, after inoculating billions of people in
Hernández Arroyo J +2 more
europepmc +2 more sources
Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review. [PDF]
Acta Derm Venereol, 2023 is missing (Short communication)
Yu D, Ren Y.
europepmc +2 more sources
Viral-Induced Rapidly Progressive Alopecia Universalis: A Case Report and Literature Review. [PDF]
Cureus, 2023 Alopecia areata is a common autoimmune condition that causes a non-scarring form of hair loss. It is associated with several viruses and diseases. One of the viruses that have been linked to alopecia areata is the coronavirus disease of 2019 (COVID-19 ...
Alotaibi MA +3 more
europepmc +2 more sources
Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosis. [PDF]
Ther Adv Neurol Disord, 2022 Herein, we report a case of alopecia universalis and transient accommodation spasm presented after alemtuzumab administration in a patient previously treated with fingolimod.
Tzanetakos D +10 more
europepmc +2 more sources
Schizophrenia in a case of alopecia universalis
Annals of Indian Psychiatry, 2017 Alopecia universalis is characterized by total loss of hair from all over the body such as the scalp, eyebrows, and limbs. Alopecia areata has been known to coexist with psychiatric disorders such as anxiety disorders and depression, although reports ...
Deepa Sangolkar +4 more
doaj +2 more sources
Alopecia Universalis Successfully Treated With Adalimumab [PDF]
JAMA Dermatology, 2014 IMPORTANCE Alopecia universalis is an uncommon form of alopecia areata (AA) involving hair loss over the entire scalp and body and is often difficult to treat. Tumor necrosis factor (TNF)inhibitors have been largely unsuccessful in treating AA and have been reported to induce or worsen AA in patients.We report herein a case of alopecia universalis ...
Elizabeth A Gordon Spratt +2 more
openaire +4 more sources
Hairless Gene Nonsense Mutations in Alopecia Universalis: A Case Report [PDF]
Iranian Journal of Public Health, 2021 Alopecia universalis (AU) congenital, known as generalized atrichia, is a severe form of autosomal recessive alopecia that results in complete hair loss of scalp and body. Mutations in the human hairless gene (HR) are associated with the phenotype of the
Hamed Heidary +4 more
doaj +2 more sources
Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis [PDF]
Journal of dermatology (Print)This post-hoc analysis of the ALLEGRO phase 2b/3 study (NCT03732807) evaluated the efficacy and safety of ritlecitinib, an oral Janus kinase 3/TEC family kinase inhibitor, in patients with alopecia totalis (AT) and alopecia universalis (AU).
Banerjee, Anindita +16 more
core +2 more sources